L&C BIO Co.,LTD (KOSDAQ:290650)
68,800
+3,300 (5.04%)
At close: Dec 5, 2025
L&C BIO Co.,LTD Revenue
L&C BIO Co.,LTD had revenue of 22.56B KRW in the quarter ending September 30, 2025, with 21.66% growth. This brings the company's revenue in the last twelve months to 79.99B, up 19.41% year-over-year. In the year 2024, L&C BIO Co.,LTD had annual revenue of 72.09B with 9.35% growth.
Revenue (ttm)
79.99B
Revenue Growth
+19.41%
P/S Ratio
21.17
Revenue / Employee
567.32M
Employees
141
Market Cap
1,693.78B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5,504.84B |
| Celltrion | 3,895.99B |
| ALTEOGEN | 202.18B |
| ABL Bio | 88.44B |
| SK Biopharmaceuticals | 675.41B |
| Yuhan | 2,136.67B |
| LigaChem Biosciences | 159.27B |
| Peptron | 6.19B |